Form 483

Neutraderm, Inc. Form 483, 2022-12-09

FDA issued a Form 483 to Neutraderm, Inc. on 2022-12-09 with 6 public-safe observations.

483· Form 483 issuedHuman Drugs6 observations

Neutraderm, Inc. · Chatsworth, United States · Issued December 9, 2022

Overview

  • 6 public-safe observations are available for this inspection.
  • 6 structured CFR citations are represented.
  • 1 investigator is tied to this Form 483.

Inspectional observations

Each observation cites the regulation FDA found the firm out of compliance with.

9 Dec 2022
21 CFR 211.111

Establishment of time limitations

Cited by Gunneet Kaur

9 Dec 2022
21 CFR 211.160(b)(4)

Written calibration procedures

Cited by Gunneet Kaur

9 Dec 2022
21 CFR 211.182

Written records kept in individual logs

Cited by Gunneet Kaur

9 Dec 2022
21 CFR 211.22(c)

Approve or reject procedures or specs

Cited by Gunneet Kaur

9 Dec 2022
21 CFR 211.67(a)

Cleaning / Sanitizing / Maintenance

Cited by Gunneet Kaur

Inspected site

NINeutraderm, Inc.Chatsworth, United States

Inspection team

Cited regulations

CFR citations associated with this Form 483.

CitationWhat it coversCited
21 CFR 211.111Cited across public-safe Form 483 observations1x
21 CFR 211.160(b)(4)Cited across public-safe Form 483 observations1x
21 CFR 211.182Cited across public-safe Form 483 observations1x
21 CFR 211.22(c)Cited across public-safe Form 483 observations1x
21 CFR 211.67(a)Cited across public-safe Form 483 observations1x
21 CFR 211.67(b)(3)Cited across public-safe Form 483 observations1x

Source document

PDF
PDF available

Form 483 source document

The source document is available to authorized Atlas users.

Full 483 report

Get the verbatim text of all 6 observations

The source PDF, so your team sees exactly what was cited and how it was answered.

  • The site's full inspection history around this Form 483
  • Whether these citations escalated to a warning letter
  • The investigators involved and the citations they repeat elsewhere